Daiichi Sankyo Taiwan Ltd. clinical trials
A country office of Daiichi Sankyo
The registry lists 2 studies whose lead sponsor is Daiichi Sankyo Taiwan Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 3, 2022.
Registry sponsor names on this page
- Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company2 studies
Something wrong with this grouping? Tell us on the Daiichi Sankyo page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Daiichi Sankyo studies →
- DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) ProteinCompletedNCT03368196Phase 1
Sponsor listed in the registry: Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company
- Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)CompletedNCT03672097Phase 4
Sponsor listed in the registry: Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company